Moneycontrol
Get App
SENSEX NIFTY
you are here:

Sequent Scientific Ltd.

BSE: 512529 | NSE: SEQUENT |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE807F01027 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 20, 16:00
94.45 -0.70 (-0.74%)
Volume
AVERAGE VOLUME
5-Day
87,494
10-Day
61,214
30-Day
68,038
16,782
  • Prev. Close

    95.15

  • Open Price

    96.05

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 20, 15:56
94.15 -1.10 (-1.15%)
Volume
AVERAGE VOLUME
5-Day
750,509
10-Day
532,386
30-Day
698,427
132,071
  • Prev. Close

    95.25

  • Open Price

    95.25

  • Bid Price (Qty.)

    94.15 (236)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Sequent Scienti

  • Feb 05, 2020 14:21 Source: BSE

    Sequent Scientific - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 05, 2020 for Agnus Holdings Pvt Ltd

  • Feb 03, 2020 12:30 Source: BSE

    Sequent Scientific - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    We enclose herewith a copy of Press Release that is being issued by the Company, today, in connection with ''''Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai''''.

  • Jan 31, 2020 14:30 Source: BSE

    Sequent Scientific - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published on January 29, 2020 in ''The Free Press Journal'' and ''Navshakti'' newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019.

  • Jan 28, 2020 13:17 Source: BSE

    Sequent Scientific - Outcome Of Board Meeting Held On January 28, 2020 Along With Unaudited Financial Results (Standalone & Consolidated) And Press Release For The Quarter And Nine Months Ended December 31, 2019

    Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2019. In this regard, kindly find enclosed the following: 1. A copy of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2019. 2. A copy of Press Release and Investors Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2019. The Board Meeting commenced at 11:15 A.M. and concluded at 1:00 P.M.

  • Jan 21, 2020 11:20 Source: NSE

    Sequent Scientific Limited

    Sequent Scientific Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Tuesday, January 28, 2020 to discuss its 3QFY20 financial results. The Conference call details are enclosed.URL for prior (early) registration:https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=105744&linkSecurityString=34606560

  • Jan 21, 2020 10:47 Source: BSE

    Sequent Scientific - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Tuesday, January 28, 2020 to discuss its 3QFY20 financial results. The Conference call details are enclosed. URL for prior (early) registration: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=105744&linkSecurityString=34606560

  • Jan 17, 2020 18:11 Source: BSE

    Sequent Scientific - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith copies of advertisement published in today''''s edition of Business Standard - All India edition and Mumbai Lakshadeep - Mumbai edition, for Notice of the Meeting of the Board of Directors of the Company to be held on Tuesday, January 28, 2020, inter-alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2019.

  • Jan 16, 2020 15:27 Source: BSE

    Sequent Scientific - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2019

    SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2020 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019 as required under Regulation 33(3)(a) of the Listing Regulations. Further, in continuation of our intimation dated December 28, 2019 and pursuant to Company''''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from January 1, 2020 to January 30, 2020 (both days inclusive).

  • Jan 15, 2020 12:42 Source: BSE

    Sequent Scientific - Shareholding for the Period Ended December 31, 2019

    Sequent Scientific Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here

  • Jan 10, 2020 13:02 Source: BSE

    Sequent Scientific - Statement Of Investor Complaints For The Quarter Ended December 2019

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- Krunal Shah
    Designation :- Company Secretary and Compliance Officer

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jan 28, 2020
Remark : Quarterly Results